Diagnostic Accuracy Of Fecal Occult Blood Tests For Detecting Proximal Versus Distal Colorectal Neoplasia: A Systematic Review And Meta-Analysis

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9(12):e1001352. doi:10.1371/journal.pmed.100135223226108
   PubMed Web of Science ®Google Scholar
• Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106–1114.24047060
   PubMed Web of Science ®Google Scholar
• Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology. 2017;152(5):1217–1237 e1213. doi:10.1053/j.gastro.2016.08.05327769517
   PubMed Web of Science ®Google Scholar
• Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64(10):1637–1649. doi:10.1136/gutjnl-2014-30908626041752
   PubMed Web of Science ®Google Scholar
• Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut. 2015;64(8):1327–1337. doi:10.1136/gutjnl-2014-30807426041750
   PubMed Web of Science ®Google Scholar
• Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126(7):1674–1680. doi:10.1053/j.gastro.2004.02.01815188160
   PubMed Web of Science ®Google Scholar
• Zorzi M, Hassan C, Capodaglio G, et al. Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test. Gut. 2017;67(12):2124–2130. doi:10.1136/gutjnl-2017-31475329101260
   PubMed Web of Science ®Google Scholar
• Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171. doi:10.7326/M13-148424658694
   PubMed Web of Science ®Google Scholar
• Haug U, Knudsen AB, Brenner H, Kuntz KM. Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review. Expert Rev Mol Diagn. 2011;11(6):605–616. doi:10.1586/erm.11.4121745014
   PubMed Web of Science ®Google Scholar
• Hirai HW, Tsoi KK, Chan JY, et al. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies. Aliment Pharmacol Ther. 2016;43(7):755–764. doi:10.1111/apt.1355626858128
   PubMed Web of Science ®Google Scholar
• Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467. doi:10.1136/bmj.g246724922745
   PubMed Web of Science ®Google Scholar
• Moher DSL, Clarke M, Ghersi D, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi:10.1186/2046-4053-4-125554246
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. doi:10.7326/0003-4819-155-8-201110180-0000922007046
   PubMed Web of Science ®Google Scholar
• Thomas WM, Hardcastle JD, Jackson J, Pye G. Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients. Br J Cancer. 1992;65(4):618–620. doi:10.1038/bjc.1992.1251562472
   PubMed Web of Science ®Google Scholar
• Hope RL, Chu G, Hope AH, Newcombe RG, Gillespie PE, Williams SJ. Comparison of three faecal occult blood tests in the detection of colorectal neoplasia. Gut. 1996;39(5):722–725. doi:10.1136/gut.39.5.7229014773
   PubMed Web of Science ®Google Scholar
• Greenberg PD, Bertario L, Gnauck R, et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol. 2000;95(5):1331–1338. doi:10.1111/j.1572-0241.2000.02032.x10811348
   PubMed Web of Science ®Google Scholar
• Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345(8):555–560. doi:10.1056/NEJMoa01032811529208
   PubMed Web of Science ®Google Scholar
• Nakama H, Zhang B, Fattah ASMA, Kamijo N, Zhang X. Characteristics of colorectal cancer that produce positive immunochemical occult blood test results on stool obtained by digital rectal examination. Can J Gastroenterol. 2001;15(4):227–230. doi:10.1155/2001/46812511331923
   PubMed Web of Science ®Google Scholar
• Sung JJY, Chan FKL, Leung WK, et al. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology. 2003;124(3):608–614. doi:10.1053/gast.2003.5009012612899
   PubMed Web of Science ®Google Scholar
• Young GP, St John DJ, Cole SR, et al. Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin. J Med Screen. 2003;10(3):123–128. doi:10.1177/09691413030100030514561263
   PubMed Web of Science ®Google Scholar
• Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129(2):422–428. doi:10.1016/j.gastro.2005.05.05616083699
   PubMed Web of Science ®Google Scholar
• Nakazato M, Yamano HO, Matsushita HO, et al. Immunologic fecal occult blood test for colorectal cancer screening. Japan Med Assoc J. 2006;49(5–6):203–207.
   Google Scholar
• Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008;149(7):441–450. doi:10.7326/0003-4819-149-7-200810070-0000418838724
   PubMed Web of Science ®Google Scholar
• Shastri Y, Loitsch S, Hoepffner N, et al. Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study. Am J Gastroenterol. 2008;103(6):1496–1504. doi:10.1111/j.1572-0241.2008.01824.x18510609
   PubMed Web of Science ®Google Scholar
• Bjerregaard NC, Tottrup A, Sorensen HT, Laurberg S. Detection of colorectal cancer in symptomatic outpatients without visible rectal bleeding: validity of the fecal occult blood test. Clin Epidemiol. 2009;1:119–124.20865093
   PubMedGoogle Scholar
• Graser A, Stieber P, Nagel D, et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut. 2009;58(2):241–248. doi:10.1136/gut.2008.15644818852257
   PubMed Web of Science ®Google Scholar
• Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009;150(3):162–169. doi:10.7326/0003-4819-150-3-200902030-0000519189905
   PubMed Web of Science ®Google Scholar
• Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol. 2010;105(3):682–690. doi:10.1038/ajg.2009.66819953091
   PubMed Web of Science ®Google Scholar
• Oono Y, Iriguchi Y, Doi Y, et al. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Clin Chim Acta. 2010;411(11–12):802–805. doi:10.1016/j.cca.2010.02.05720184867
   PubMed Web of Science ®Google Scholar
• Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105(9):2017–2025. doi:10.1038/ajg.2010.17920502450
   PubMed Web of Science ®Google Scholar
• Haug U, Kuntz KM, Knudsen AB, Hundt S, Brenner H. Sensitivity of immunochemical faecal occult blood testing for detecting left-vs right-sided colorectal neoplasia. Br J Cancer. 2011;104(11):1779–1785. doi:10.1038/bjc.2011.16021559011
   PubMed Web of Science ®Google Scholar
• Khalid-de Bakker CAJ, Jonkers DMAE, Sanduleanu S, et al. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas. Cancer Prev Res. 2011;4(10):1563–1571. doi:10.1158/1940-6207.CAPR-11-0076
   Web of Science ®Google Scholar
• de Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol. 2012;107(10):1570–1578. doi:10.1038/ajg.2012.24922850431
   PubMed Web of Science ®Google Scholar
• Wong CKW, Fedorak RN, Prosser CI, Stewart ME, Van Zanten SV, Sadowski DC. The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer. Int J Colorectal Dis. 2012;27(12):1657–1664. doi:10.1007/s00384-012-1518-322696204
   PubMed Web of Science ®Google Scholar
• Chiu HM, Lee YC, Tu CH, et al. Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin Gastroenterol Hepatol. 2013;11(7):832-838e831-832. doi:10.1016/j.cgh.2013.01.013
   Web of Science ®Google Scholar
• Kaul A, Shah A, Magill FH, Hawkins SA, Skaife P. Immunological faecal occult blood testing: A discriminatory test to identify colorectal cancer in symptomatic patients. Int J Surg. 2013;11(4):329–331. doi:10.1016/j.ijsu.2013.02.01323459187
   PubMed Web of Science ®Google Scholar
• Koga Y, Yamazaki N, Yamamoto Y, et al. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2013;22(10):1844–1852. doi:10.1158/1055-9965.EPI-13-051223950216
   PubMed Web of Science ®Google Scholar
• Lee YC, Chiu HM, Chiang TH, et al. Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions. BMJ Open. 2013;3(10):e003989. doi:10.1136/bmjopen-2013-003989
   Web of Science ®Google Scholar
• Kim BC, Joo J, Chang HJ, et al. A predictive model combining fecal calgranulin B and fecal occult blood tests can improve the diagnosis of colorectal cancer. PLoS One. 2014;9(9):e106182. doi:10.1371/journal.pone.010618225188229
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287–1297. doi:10.1056/NEJMoa131119424645800
   PubMed Web of Science ®Google Scholar
• Castro I, Estevez P, Cubiella J, et al. Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci. 2015;60(5):1424–1432. doi:10.1007/s10620-014-3434-625407805
   PubMed Web of Science ®Google Scholar
• Kim NH, Yang HJ, Park SK, et al. Does low threshold value use improve proximal neoplasia detection by fecal immunochemical test? Dig Dis Sci. 2016;61(9):2685–2693. doi:10.1007/s10620-016-4169-327107865
   PubMed Web of Science ®Google Scholar
• Brenner H, Niedermaier T, Chen H. Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin. Int J Cancer. 2017;140(9):2015–2022. doi:10.1002/ijc.3062928152558
   PubMed Web of Science ®Google Scholar
• Jung YS, Park CH, Kim NH, Park JH, Park DI, Sohn CI. Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results. PLoS One. 2018;13(1):e0191125. doi:10.1371/journal.pone.019112529324874
   PubMed Web of Science ®Google Scholar
• Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696. doi:10.1056/NEJMoa110037022356322
   PubMed Web of Science ®Google Scholar
• Click B, Pinsky PF, Hickey T, Doroudi M, Schoen RE. Association of colonoscopy adenoma findings with long-term colorectal cancer incidence. JAMA. 2018;319(19):2021–2031. doi:10.1001/jama.2018.580929800214
   PubMed Web of Science ®Google Scholar
• Force USPST, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–2575. doi:10.1001/jama.2016.598927304597
   PubMed Web of Science ®Google Scholar
• Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut. 2012;61(10):1439–1446. doi:10.1136/gutjnl-2011-30084322156981
   PubMed Web of Science ®Google Scholar
• Crotta S, Segnan N, Paganin S, Dagnes B, Rosset R, Senore C. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol. 2012;10(6):633–638. doi:10.1016/j.cgh.2012.02.03022426085
   PubMed Web of Science ®Google Scholar
• van Roon AH, Wilschut JA, Hol L, et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol. 2011;9(4):333–339. doi:10.1016/j.cgh.2010.12.01221185397
   PubMed Web of Science ®Google Scholar